Opella: New study demonstrates successful cough treatment extends beyond symptom relief

PARIS, Oct. 15, 2026 /PRNewswire/ — A new real-world study from Opella, the maker of Mucosolvan and Bisolvon, provides pharmacists with compelling evidence that the success of a cough treatment should be measured by its impact on a patient’s overall well-being, alongside traditional symptomatic relief. With most consumers1 making treatment decisions in the pharmacy, the pharmacist’s […]